Closing the serological gap in the diagnostic testing for COVID‐19: The value of anti‐SARS‐CoV‐2 IgA antibodies

During coronavirus disease 2019 (COVID‐19) pandemic, the early diagnosis of patients is a priority. Serological assays, in particular immunoglobulin (Ig)M and IgG anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), have today several applications but the interpretation of their result...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Virol
Päätekijät: Infantino, Maria, Manfredi, Mariangela, Grossi, Valentina, Lari, Barbara, Fabbri, Sergio, Benucci, Maurizio, Fortini, Alberto, Damiani, Arianna, Mobilia, Emanuela Maria, Panciroli, Marta, Pancani, Silvia, Pesce, Giampaola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436746/
https://ncbi.nlm.nih.gov/pubmed/32790181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26422
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia